MedTrace Logo

Blood Test for Ovarian Cancer Associated Antibodies (CAAb)

NCT00327925 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2007-03-02

No results posted yet for this study

Summary

Blood is collected from patients and cultured in a CimTube (a test tube with stimulation media) for several days. Following the culture step, the supernatant fluid is tested for the presence of CAAb on experimental test kits.

Null Hypothesis: There is no relationship between the presence or absence of ovarian cancer (OC) and the CAAb i.e. d=0.

Alternative Hypothesis: The expectation of the CAAb in the cancer population differs from that of the control population, i.e. m1 is not equal to m2. Since the sign of the difference is not important, the test will be two-sided.

Conditions

Interventions

PROCEDURE

Find Cancer Associated Antibodies

Sponsors & Collaborators

  • Lab Discoveries Ltd.

    lead INDUSTRY

Principal Investigators

  • Tamar J. Cohen, Ph.D · Lab Discoveries Ltd.

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Completion
2008-06-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00327925 on ClinicalTrials.gov